Influence of timolol, benzalkonium-preserved timolol, and benzalkonium-preserved brimonidine on oxidative stress biomarkers in the tear film

Tear film analysis and evaluation of optical quality: A review of the literature

(2019) A. Herbaut et al.   JOURNAL FRANCAIS D OPHTALMOLOGIE

Timolol 0.1% in Glaucomatous Patients: Efficacy, Tolerance, and Quality of Life

(2019) Letizia Negri et al.   Journal of Ophthalmology

Effect of Topical Prostaglandin F2α Analogs on Selected Oxidative Stress Parameters in the Tear Film

(2019) Lech Sedlak et al.   Medicina-Lithuania

Effects of tear film dynamics on quality of vision

(2018) Shizuka Koh et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Preservatives in glaucoma medication

(2018) David W Steven et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Maintaining a Healthy Proteome during Oxidative Stress

(2018) Dana Reichmann et al.   MOLECULAR CELL

Ocular surface toxicity from glaucoma topical medications and associated preservatives such as benzalkonium chloride (BAK)

(2016) Alberto Aguayo Bonniard et al.   Expert Opinion on Drug Metabolism & Toxicology

Measurement and meaning of cellular thiol:disufhide redox status

(2016) Marcelo A. Comini   FREE RADICAL RESEARCH

Antioxidant responses and cellular adjustments to oxidative stress

(2015) Cristina Espinosa-Diez et al.   Redox Biology

Free radicals, reactive oxygen species, oxidative stress and its classification

(2014) Volodymyr I. Lushchak   CHEMICO-BIOLOGICAL INTERACTIONS

The Pathophysiology and Treatment of Glaucoma

(2014) Robert N. Weinreb et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Glaucoma therapy and ocular surface disease

(2013) Zane Anwar et al.   CURRENT OPINION IN OPHTHALMOLOGY

Complexity of the tear film: Importance in homeostasis and dysfunction during disease

(2013) D.A. Dartt et al.   EXPERIMENTAL EYE RESEARCH

Causes and Consequences of CysteineS-Glutathionylation

(2013) Christina L. Grek et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Benzalkonium Chloride and Glaucoma

(2013) Carol A. Rasmussen et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Prevalence and Risk Factors for Ocular Surface Disease among Patients Treated over the Long Term for Glaucoma or Ocular Hypertension

(2012) Christophe Baudouin et al.   EUROPEAN JOURNAL OF OPHTHALMOLOGY

Antioxidant Defenses in the ocular surface

(2012) Ying Chen et al.   Ocular Surface

Antioxidant enzyme mRNA expression in conjunctival epithelium of healthy human subjects

(2011) Rosa M. Corrales et al.   CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE

Symptoms and Signs of Tear Film Dysfunction in Glaucomatous Patients

(2011) Cristiana Valente et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Preservatives in eyedrops: The good, the bad and the ugly

(2010) Christophe Baudouin et al.   PROGRESS IN RETINAL AND EYE RESEARCH

Prevalence of Ocular Surface Disease in Glaucoma Patients

(2009) Eamon W. Leung et al.   JOURNAL OF GLAUCOMA

In VitroEffects of Preservative-Free Tafluprost and Preserved Latanoprost, Travoprost, and Bimatoprost in a Conjunctival Epithelial Cell Line

(2008) Emmanuelle Brasnu et al.   CURRENT EYE RESEARCH

Glutathione: Overview of its protective roles, measurement, and biosynthesis

(2008) Henry Jay Forman et al.   MOLECULAR ASPECTS OF MEDICINE

Regulation of glutathione synthesis

(2008) Shelly C. Lu   MOLECULAR ASPECTS OF MEDICINE

The Ocular Surface of Glaucoma Patients Treated over the Long Term Expresses Inflammatory Markers Related to Both T-Helper 1 and T-Helper 2 Pathways

(2007) Christophe Baudouin et al.   OPHTHALMOLOGY